development of a diagnostic service for pseudohypoparathyroidism type 1b jennifer greatwood

14
Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

Upload: leon-garrett

Post on 23-Dec-2015

217 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

Development of a DiagnosticService for

Pseudohypoparathyroidism type 1b

Jennifer Greatwood

Page 2: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

Pseudohypoparathyroidism (PHP)

• Introduction- Pseudohypoparathyroidism

• Screening strategy

• Results

• Conclusion

Page 3: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

Pseudohypoparathyroidism (PHP) is characterised by hypocalcaemia, hyperphosphataemia and elevated levels of serum parathyroid hormone (PTH).

Besides PTH resistance, affected individuals may show distinctive but variable features. These clinical findings are termed Albright’s hereditary osteodystrophy (AHO).

Pseudohypoparathyroidism (PHP)

short stature, obesity, short limbs

round face,mental retardation

Brachydactyly- hands/feet

Characteristic ‘dimpling’ replacing the knuckles

Page 4: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

PHP variants

PHP type 1a PPHPPseudopseudohypoparathyroidism

PHP type 1b

PHP

(PTH resistance)

+

AHO phenotype

AHO

phenotype

PHP

(PTH resistance)

Page 5: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

PTH is synthesised by the parathyroid glands and regulates calcium and phosphorous concentrations in extracellular fluid by acting on target organs.

In PHP, the biochemical characteristics are caused by end–organ resistance to PTH rather than deficiency of PTH.

Parathyroid hormone

The PTH normally mediates its actions via a Gs-coupled receptor.

In PHP hormone resistance is due to a deficiency of the Gs subunit.

Page 6: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

GNAS locus

• GNAS is a complex imprinted locus on 20q13. • Encodes the Gs subunit, which is generated from the most downstream promoter

(exon 1).• Gs is imprinted in a tissue-specific manner, being expressed primarily from the

maternal allele in certain hormone responsive tissues, such as the renal proximal tubules.

• PHP type-1b is associated with epimutations at the GNAS locus on chromosome 20q13.

Page 7: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

GNAS locus & PHP-1b

Sporadic PHP-1b

Variable GNAS imprinting defects that may involve the upstream DMRs NESP55 & NESPAS, in addition to GNAS exon 1A.

This epigenotype can result from: - maternally inherited microdeletions in NESP55

- paternal UPD of 20q or

- an epimutation affecting the GNAS locus.

Familial PHP-1b LOMM at GNAS exon 1A. This epigenotype has been associated with maternally inherited microdeletions in STX16 gene.

Page 8: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

Screening strategy for PHP- type 1b

Bisulphite treatment of DNABisulphite treatment of DNA

Methylation-specific PCR to examine the methylation status of the three DMRs:GNAS exon 1A, NESP55 and NESP-AS/XLS.

Methylation-specific PCR to examine the methylation status of the three DMRs:GNAS exon 1A, NESP55 and NESP-AS/XLS.

Microdeletion analysis by long range PCR to examine the STX16 and

NESP55 genes for known microdeletions

Microdeletion analysis by long range PCR to examine the STX16 and

NESP55 genes for known microdeletions

Microsatellite analysis to test for paternal uniparental disomy of 20q Microsatellite analysis to test for

paternal uniparental disomy of 20q

If a methylation defect is found: If a methylation defect is found:

NESP55 STX16

Page 9: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

MS-PCR results

Page 10: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

MS-PCR results

• 6/8 patients referred for PHP showed complete LOM at the GNAS exon 1A DMR.

• Additional methylation defects at the upstream DMRs NESP55 and NESPAS were also observed in all 6 patients.

• 4/6 cases showed complete hypomethylation at GNAS & NESPAS and complete hypermethylation at NESP55.

• 2/6 cases still had residual methylation at NESPAS.

• This epigenotype is associated with sporadic forms of PHP-1b and can be due to:

- maternally inherited microdeletions in NESP55

- paternal UPD of 20q or

- an epimutation affecting the GNAS locus.

Page 11: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

Screening strategy for PHP- type 1b

Bisulphite treatment of DNABisulphite treatment of DNA

Methylation-specific PCRMethylation-specific PCR

Microdeletion analysis by long range PCR to examine the STX16 and

NESP55 genes for known microdeletions

Microdeletion analysis by long range PCR to examine the STX16 and

NESP55 genes for known microdeletions

Microsatellite analysis to test for paternal uniparental disomy of 20q Microsatellite analysis to test for

paternal uniparental disomy of 20q

If a methylation defect is found: If a methylation defect is found:

NESP55 STX16

Page 12: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

Results continued…..

• No evidence of known microdeletions in NESP55 (sporadic).

• No evidence of UPD.

• No known microdeletions in STX16 found (familial).

• All 6 cases are believed to be caused by an epigenetic abnormality.

Page 13: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

• PHP type-1b is characterised by hypocalcaemia and hyperphosphataemia due to end-organ resistance to PTH, which acts via a Gs- coupled receptor.

• PHP-1b is associated with epimutations at the GNAS locus on chromosome 20q13.

• 6/8 patients had methylation defects at the GNAS locus which were consistent with a diagnosis of PHP-1b.

• This test has been validated and is now available as a diagnostic test.

In conclusion…..

We are now offering a molecular genetic diagnostic service for PHP-1b at the WRGL Please contact the lab for further information. [email protected]

Page 14: Development of a Diagnostic Service for Pseudohypoparathyroidism type 1b Jennifer Greatwood

Acknowledgments

• Dr D Mackay

• Jonathan Callaway

• Dr D Robinson

• Dr J Harvey